Lege artis - Das Magazin zur ärztlichen Weiterbildung, Table of Contents PSYCH up2date 2016; 10(02): 115-132DOI: 10.1055/s-0041-107999 Angststörungen, Zwangsstörungen und stressassoziierte Störungen Panikstörung und Agoraphobie Petra Kindermann , Marion Mühlberger , Ulrich Voderholzer Recommend Article Abstract Buy Article Full Text References Literatur 1 Weissman MM, Bland RC, Canino GJ. et al. The cross-national epidemiology of panic disorder. Archs Gen Psychiatry 1997; 54: 305-309 2 Wittchen HU, Jacobi F. Die Versorgungssituation psychischer Störungen in Deutschland. Eine klinisch-epidemiologische Abschätzung anhand des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2001; 44: 993-1000 3 Jacobi F, Hofler M, Siegert J. et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2014; 23: 304-319 4 Somers JM, Goldner EM, Waraich P. et al. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry 2006; 51: 100-113 5 In-Albon T, Margraf J. Panik und Agoraphobie. In: Wittchen HU, Hoyer J. Hrsg. Klinische Psychologie und Psychotherapie. Berlin, Heidelberg: Springer Verlag; 2011 6 Bandelow B, Wiltink J, Alpers GW. et al. Deutsche S3-Leitlinie Behandlung von Angststörungen. Accessed January 28, 2016 at: https://www.dgppn.de/fileadmin/user_upload/_medien/download/pdf/kurzversion-leitlinien/S3-LL_Lang_Angststörungen_2014.pdf 7 National Institute for Health and Clinical Excellence (NICE). Anxiety: Management of anxiety (panic diorder with or without agoraphobia and generalized anxiety disorder) in adults in primary, secondary and community care. 2011 8 Dilling H, Mombour W, Schmidt MH. Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien. Bern: Hans Huber Verlag; 2008 9 Asmundson GJ, Taylor S, Smits JA. Panic disorder and agoraphobia: an overview and commentary on DSM-5 changes. Depress Anxiety 2014; 31: 480-486 10 Klein DF. Anxiety reconceptualized. Compr Psychiatry 1980; 21: 411-427 11 Wittchen H-U, Gloster AT, Beesdo-Baum K. et al. Agoraphobia: A review of the diagnostic classificatory position and criteria. Depress Anxiety 2010; 27: 113-133 12 Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician 2015; 91: 617-624 13 Batterham PJ, Mackinnon AJ, Christensen H. The panic disorder screener (PADIS): Development of an accurate and brief population screening tool. Psychiatry Res 2015; 228: 72-76 14 Oromendia P, Bonillo A, Molinuevo B. Web-based screening for Panic Disorder: Validity of a single-item instrument. J Affect Disord 2015; 180: 138-141 15 Bandelow B. Panic and agoraphobia scale (PAS). Göttingen, Bern, Toronto, Seattle: Hogrefe & Huber Publishers; 1999 16 Shear MK, Brown TA, Barlow DH. et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997; 154: 1571-1575 17 Chambless DL, Caputo GC, Bright P. et al. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 1984; 52: 1090-1097 18 Ehlers A, Margraf J. Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung (AKV). Manual. 2. Aufl.. Göttingen: Beltz Test GmbH; 2001 19 Ehlers A, Margraf J, Chambless DL. Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung (AKV). 2.. Aufl. Weinheim: Beltz Test Gesellschaft; 2001 20 Kessler RC, Chiu WT, Jin R. et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-424 21 Wittchen U, Jacobi F, Rehm J. et al. The size and burden of mental disorders and other disorders in brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-679 22 Goodwin RD, Faravelli C, Rosi S. et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol 2005; 15: 435-443 23 Angst J, Gamma A, Baldwin DS. et al. The generalized anxiety spectrum: prevalence, onset, course and outcome. Eur Arch Psychiatry Clin Neurosci 2009; 259: 37-45 24 Wittchen HU, Reed V, Kessler RC. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch Gen Psychiatry 1998; 55: 1017-1024 25 Reed V, Wittchen HU. DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: how specific are panic attacks?. J Psychiatr Res 1998; 32: 335-345 26 Altinbas G, Altinbas K, Guloksuz SA. et al. Temperament characteristics in patients with panic disorder and their first-degree relatives. Compr Psychiatry 2015; 60: 73-77 27 Bruce SE, Yonkers KA, Otto MW. et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-1187 28 Wittchen HU. Der Langzeitverlauf unbehandelter Angststörungen: Wie häufig sind Spontanremissionen? [The long-term course of untreated anxiety disorders: What is the frequency of spontaneous remission?]. Verhaltenstherapie 1991; 1: 273-282 29 Craske MG, Simos G. Panic disorder and agoraphobia. In: Simos G, Hofmann SG. Hrsg. CBT in anxiety disorders: A practitioner book. New York: John Wiley & Sons; 2013 30 Keller MB, Yonkers KA, Warshaw MG. et al. Remission and relapse in subjects with panic disorder and agoraphobia: A prospective short interval naturalistic follow-up. J Nerv Ment Dis 1994; 182: 290-296 31 Lim SW, Ko EM, Shin DW. et al. Clinical symptoms associated with suicidality in patients with panic disorder. Psychopathology 2015; 48: 137-144 32 Brown TA, Campbell LA, Lehman CL. et al. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnormal Psychology 2001; 110: 585 33 Sareen J, Jacobi F, Cox BJ. et al. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med 2006; 166: 2109-2116 34 Margraf J, Schneider S. Lehrbuch der Verhaltenstherapie. Berlin: Springer Verlag; 2008 35 Ruhmland M, Margraf J. Effektivität psychologischer Therapien von Panik und Agoraphobie: Meta-Analysen auf Störungsebene. Verhaltenstherapie 2001; 11: 41-53 36 Foa EB, McNally RJ. Mechanisms of change in exposure therapy. In: Rapee M. Hrsg. Current controversies in the anxiety disorders. New York: Guilford Press; 1996: 329-343 37 Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull 1986; 99: 20-35 38 Craske M. Optimizing exposure therapy for anxiety disorders: An inhibitory learning and inhibitory regulation approach. Verhaltenstherapie 2015; 25: 134-143 39 Bouton ME. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 1993; 114: 80-99 40 Vlachos I, Herry C, Luthi A. et al. Context-dependent encoding of fear and extinction memories in a large-scale network model of the basal amygdala. PLoS Comput Biol 2011; 7: e1001104 41 Lissek S, Rabin SJ, McDowell DJ. et al. Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behav Res Ther 2009; 47: 111-118 42 Tabibnia G, Lieberman MD, Craske M. The lasting effects of words on feelings: Words may facilitate exposure effects to threatening images. Emotion 2008; 8: 307-317 43 Sanchez-Meca J, Rosa-Alcazar A, Marin-Martinez F. et al. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia: A meta-analysis. Clin Psychol Rev 2010; 30: 37-50 44 Mitte K. A meta-analysis of the efficacy of psycho-and pharmacotherapy in panic disorder with or without agoraphobia. J Affect Disord 2005; 88: 27-45 45 Bandelow B, Reitt M, Rover C. et al. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 2015; 30: 183-192 46 Huhn M, Tardy M, Spineli LM. et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry 2014; 71: 706-715 47 Furukawa T, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobie (Review). The Cochrane Library 2009 48 Hofmann SG, Otto MW, Pollack MH. et al. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Curr Psychiatry Rep 2015; 17: 532
